531681 — Amerise Biosciences Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹46.25m
- IN₹46.04m
- IN₹0.36m
Annual cashflow statement for Amerise Biosciences, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IAS | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -1.49 | -3.37 | 5.49 | -1.19 | -1.46 |
| Depreciation | |||||
| Non-Cash Items | 0 | 0 | 0 | — | — |
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 50.4 | -0.574 | -4.88 | -0.132 | -0.233 |
| Change in Accounts Receivable | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 48.9 | -3.94 | 0.614 | -1.32 | -1.69 |
| Other Investing Cash Flow Items | -48.9 | 3.89 | -1.5 | 1.25 | 2.67 |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -48.9 | 3.89 | -1.5 | 1.25 | 2.67 |
| Financing Cash Flow Items | 0 | 0 | 0 | 0 | 0 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0 | 0 | 0.827 | 0.073 | -0.9 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.067 | -0.058 | -0.064 | 0.007 | 0.075 |